Cargando…

Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Naja spp. African snakes

BACKGROUND: Envenomations by African snakes represent a high burden in the sub-Sahara region. The design and fabrication of polyspecific antivenoms with a broader effectiveness, specially tailored for its use in sub-Saharan Africa, require a better understanding of the immunological features of diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez, Aarón, Sánchez, Andrés, Durán, Gina, Villalta, Mauren, Segura, Álvaro, Vargas, Mariángela, Solano, Daniela, Herrera, María, Sánchez, Melvin, Gutiérrez, José María, León, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426987/
https://www.ncbi.nlm.nih.gov/pubmed/37582064
http://dx.doi.org/10.1371/journal.pntd.0011545
_version_ 1785090151518568448
author Gómez, Aarón
Sánchez, Andrés
Durán, Gina
Villalta, Mauren
Segura, Álvaro
Vargas, Mariángela
Solano, Daniela
Herrera, María
Sánchez, Melvin
Gutiérrez, José María
León, Guillermo
author_facet Gómez, Aarón
Sánchez, Andrés
Durán, Gina
Villalta, Mauren
Segura, Álvaro
Vargas, Mariángela
Solano, Daniela
Herrera, María
Sánchez, Melvin
Gutiérrez, José María
León, Guillermo
author_sort Gómez, Aarón
collection PubMed
description BACKGROUND: Envenomations by African snakes represent a high burden in the sub-Sahara region. The design and fabrication of polyspecific antivenoms with a broader effectiveness, specially tailored for its use in sub-Saharan Africa, require a better understanding of the immunological features of different Naja spp. venoms of highest medical impact in Africa; and to select the most appropriate antigen combinations to generate antivenoms of wider neutralizing scope. METHODOLOGY/PRINCIPAL FINDINGS: Rabbit-derived monospecific antisera were raised against the venoms of five spitting cobras and six non-spitting cobras. The effects of immunization in the animal model were assessed, as well as the development of antibody titers, as proved by immunochemical assays and neutralization of lethal, phospholipase A(2) and dermonecrotic activities. By the end of the immunization schedule, the immunized rabbits showed normal values of all hematological parameters, and no muscle tissue damage was evidenced, although alterations in aspartate aminotransferase (AST) and alkaline phosphatase (ALP) suggested a degree of hepatic damage caused mainly by spitting cobra venoms. Immunologic analyses revealed a considerable extent of cross-reactivity of monospecific antisera against heterologous venoms within the spitting and no-spitting cobras, yet some antisera showed more extensive cross-reactivity than others. The antisera with the widest coverage were those of anti-Naja ashei and anti-N. nigricollis for the spitting cobras, and anti-N. haje and anti-N. senegalensis for the non-spitting cobras. CONCLUSIONS/SIGNIFICANCE: The methods and study design followed provide a rationale for the selection of the best combination of venoms for generating antivenoms of high cross-reactivity against cobra venoms in sub-Saharan Africa. Results suggest that venoms from N. ashei, N. nigricollis within the spitting cobras, and N. haje and N. senegalensis within the non-spitting cobras, generate antisera with a broader cross-reactivity. These experimental results should be translated to larger animal models used in antivenom elaboration to assess whether these predictions are reproduced.
format Online
Article
Text
id pubmed-10426987
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-104269872023-08-16 Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Naja spp. African snakes Gómez, Aarón Sánchez, Andrés Durán, Gina Villalta, Mauren Segura, Álvaro Vargas, Mariángela Solano, Daniela Herrera, María Sánchez, Melvin Gutiérrez, José María León, Guillermo PLoS Negl Trop Dis Research Article BACKGROUND: Envenomations by African snakes represent a high burden in the sub-Sahara region. The design and fabrication of polyspecific antivenoms with a broader effectiveness, specially tailored for its use in sub-Saharan Africa, require a better understanding of the immunological features of different Naja spp. venoms of highest medical impact in Africa; and to select the most appropriate antigen combinations to generate antivenoms of wider neutralizing scope. METHODOLOGY/PRINCIPAL FINDINGS: Rabbit-derived monospecific antisera were raised against the venoms of five spitting cobras and six non-spitting cobras. The effects of immunization in the animal model were assessed, as well as the development of antibody titers, as proved by immunochemical assays and neutralization of lethal, phospholipase A(2) and dermonecrotic activities. By the end of the immunization schedule, the immunized rabbits showed normal values of all hematological parameters, and no muscle tissue damage was evidenced, although alterations in aspartate aminotransferase (AST) and alkaline phosphatase (ALP) suggested a degree of hepatic damage caused mainly by spitting cobra venoms. Immunologic analyses revealed a considerable extent of cross-reactivity of monospecific antisera against heterologous venoms within the spitting and no-spitting cobras, yet some antisera showed more extensive cross-reactivity than others. The antisera with the widest coverage were those of anti-Naja ashei and anti-N. nigricollis for the spitting cobras, and anti-N. haje and anti-N. senegalensis for the non-spitting cobras. CONCLUSIONS/SIGNIFICANCE: The methods and study design followed provide a rationale for the selection of the best combination of venoms for generating antivenoms of high cross-reactivity against cobra venoms in sub-Saharan Africa. Results suggest that venoms from N. ashei, N. nigricollis within the spitting cobras, and N. haje and N. senegalensis within the non-spitting cobras, generate antisera with a broader cross-reactivity. These experimental results should be translated to larger animal models used in antivenom elaboration to assess whether these predictions are reproduced. Public Library of Science 2023-08-15 /pmc/articles/PMC10426987/ /pubmed/37582064 http://dx.doi.org/10.1371/journal.pntd.0011545 Text en © 2023 Gómez et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Gómez, Aarón
Sánchez, Andrés
Durán, Gina
Villalta, Mauren
Segura, Álvaro
Vargas, Mariángela
Solano, Daniela
Herrera, María
Sánchez, Melvin
Gutiérrez, José María
León, Guillermo
Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Naja spp. African snakes
title Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Naja spp. African snakes
title_full Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Naja spp. African snakes
title_fullStr Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Naja spp. African snakes
title_full_unstemmed Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Naja spp. African snakes
title_short Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Naja spp. African snakes
title_sort intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important naja spp. african snakes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426987/
https://www.ncbi.nlm.nih.gov/pubmed/37582064
http://dx.doi.org/10.1371/journal.pntd.0011545
work_keys_str_mv AT gomezaaron intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes
AT sanchezandres intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes
AT durangina intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes
AT villaltamauren intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes
AT seguraalvaro intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes
AT vargasmariangela intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes
AT solanodaniela intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes
AT herreramaria intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes
AT sanchezmelvin intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes
AT gutierrezjosemaria intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes
AT leonguillermo intragenericcrossreactivityofmonospecificrabbitantiseraagainstvenomsofthemedicallymostimportantnajasppafricansnakes